Aligos Therapeutics, Inc. Common Stock
$5.51
▼ 0.04
(-0.72%)
Volume: 44,742
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -26.6%
- MA aligned bearish
- RSI 46
🎯
Pullback
50
- -2.1% vs 20MA
💎
Value
58
- -60% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)45.9
MACD+0.011
MA trendBearish
ATR9.18%
21d mom.-26.6%
63d mom.-1.1%
vs 20MA-2.1%
RVOL(20)0.84×
52w low · 4
52w high · 14
-59.8% from 52-week high
20d support 5
· resistance 7
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$35M
PER—
PBR1.09
PSR1.10
EPS$-12.16
ROE-238.2%
ROA-114.5%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.06
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +5.15% | -26.63% | -1.08% | -21.73% | -48.74% | -39.65% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -11.27%, daily vol 4.51%. Aligos Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.